CSTL vs ECL · rev $332.1M vs P/E 35, rev $4.01B
Castle Biosciences Inc (CSTL) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CSTL revenue for 2024-12-31 was $332.1M. Net income was $18.2M. Revenue was up 51.1% from 2023-12-31 to 2024-12-31. CSTL currently screens at market cap $570.2M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CSTL currently screens at market cap $570.2M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CSTL and ECL stock pages for the full models.
Not investment advice.